A major move is in the offing as Immunome Inc (IMNM) market cap hits 800.51 million

On Friday, Immunome Inc (NASDAQ: IMNM) opened lower -6.03% from the last session, before settling in for the closing price of $9.79. Price fluctuations for IMNM have ranged from $5.15 to $16.81 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Company’s average yearly earnings per share was noted 56.81% at the time writing. With a float of $76.80 million, this company’s outstanding shares have now reached $86.96 million.

Let’s determine the extent of company efficiency that accounts for 118 employees. In terms of profitability, gross margin is 100.0%, operating margin of -1994.3%, and the pretax margin is -1875.21%.

Immunome Inc (IMNM) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immunome Inc is 11.74%, while institutional ownership is 82.19%. The most recent insider transaction that took place on Jun 03 ’25, was worth 46,900. In this transaction Director of this company bought 5,000 shares at a rate of $9.38, taking the stock ownership to the 36,415 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Director bought 7,800 for $7.78, making the entire transaction worth $60,684. This insider now owns 31,415 shares in total.

Immunome Inc (IMNM) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 56.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.72% during the next five years compared to -38.15% drop over the previous five years of trading.

Immunome Inc (NASDAQ: IMNM) Trading Performance Indicators

Check out the current performance indicators for Immunome Inc (IMNM). In the past quarter, the stock posted a quick ratio of 10.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 73.17.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.19, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -2.36 in one year’s time.

Technical Analysis of Immunome Inc (IMNM)

Looking closely at Immunome Inc (NASDAQ: IMNM), its last 5-days average volume was 0.78 million, which is a drop from its year-to-date volume of 1.05 million. As of the previous 9 days, the stock’s Stochastic %D was 68.95%. Additionally, its Average True Range was 0.57.

During the past 100 days, Immunome Inc’s (IMNM) raw stochastic average was set at 55.56%, which indicates a significant increase from 55.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.43% in the past 14 days, which was lower than the 75.77% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $8.12, while its 200-day Moving Average is $10.62. However, in the short run, Immunome Inc’s stock first resistance to watch stands at $9.71. Second resistance stands at $10.21. The third major resistance level sits at $10.56. If the price goes on to break the first support level at $8.86, it is likely to go to the next support level at $8.51. Should the price break the second support level, the third support level stands at $8.01.

Immunome Inc (NASDAQ: IMNM) Key Stats

There are currently 87,012K shares outstanding in the company with a market cap of 800.51 million. Presently, the company’s annual sales total 9,040 K according to its annual income of -292,960 K. Last quarter, the company’s sales amounted to 2,930 K and its income totaled -41,640 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.